Flora CoffinGaëlle Combeau

Pufan LiCathrine RouletEmmanuel Lejeune

The Global Pharmaceutical

Industry

Political Pressure on margins offer tax or cost advantagesPrice or reimbursement controled by the government

Economic

Mergers between BiothecsMature markets emerging onesTighter regulatory controls on clinical trialsNiche areas are becoming crowdedFree tradePatented drugs : 18% => 8%Generic increase 40%Health care spending boomed

Socioculturel Life expectency in developed countries increase by over 20 yearsAgeing population

Technological

High levels of R&D spendingMore creative and efficientMore expensive hight technology solutionsPenicilin = major discoveryThalidonide tragedyComputers can print prescriptionsBiopharmaceuticals became mainstream

LegalStringent government regulationsLegislation = fixed period on patent protection

Key drivers / Major trends

Legislation on patent protection led to the appearance of generic medecines

Discovery of Penicilin

Dyestuffs were found to have antiseptic properties

Mergers, consolidation and globalisation of domestic companies

Key strategic capabilities are R&D, sales and marketing

Health search is one of the top reasons for searches on Internet which increases patient demands on therapies